Cargando…
Discovery and Preclinical Development of Orally Active Small Molecules that Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism
An orally active follicle stimulating hormone receptor allosteric agonist would provide a preferred treatment for over 16 million infertile women of reproductive age in low complexity methods (ovulation induction-intrauterine insemination) or in high complexity methods (controlled ovarian stimulatio...
Autores principales: | Nataraja, Selva, Yu, Henry, Guner, Joie, Palmer, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845544/ https://www.ncbi.nlm.nih.gov/pubmed/33519465 http://dx.doi.org/10.3389/fphar.2020.602593 |
Ejemplares similares
-
Erratum: Discovery and Preclinical Development of Orally Active Small Molecules That Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism
por: Frontiers Production Office,
Publicado: (2021) -
Pharmacological Programming of Endosomal Signaling Activated by Small Molecule Ligands of the Follicle Stimulating Hormone Receptor
por: Sposini, Silvia, et al.
Publicado: (2020) -
Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors
por: Nataraja, Selvaraj G., et al.
Publicado: (2015) -
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
por: Zimmer, Daniel P., et al.
Publicado: (2020) -
Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor
por: De Pascali, Francesco, et al.
Publicado: (2021)